For a long time now, men have been on the spot light on their sexual dysfunction. It is actually very easy to forget that women can also have a sexual dysfunction too and just like men they are looking for a solution to these dysfunction. A lot of things can cause a dysfunction in a woman. Studies have shown that the sexual dysfunction affect about 30 to 50 percent of couples. This is a very big number of people who are affected. This dysfunction occurs because a woman is tired or can not get an orgasm or they do not get aroused at all. Female Viagra used for treatment women sexual dysfunction.
There are some women who can barely get aroused at all and no matter how hard a man tries to get their body stimulated they fail miserably. This could be because the woman is anxious about something or they are thinking too hard. Studies have indicated that failure of some women to feel aroused occurs in about 15 percent of the women population. The man might be left thinking that the woman does not love him and his better off leaving her than hanging on to someone he can barely turn on. Leaving is not necessary though. What you need to do is for both of you to seek some sort of professional help. This is because what she has is a sexual dysfunction that can be taken care of and with time maybe corrected. Dont loose a great love by thinking she simply doesnt love you.
There are some women who do not get an orgasm during sexual intercourse. It has actually been observed that about 40 percent of the women cannot get an orgasm during sex but could get one if they stimulated themselves or the man did it for them after the act. So if you have never had an orgasm during sex do not be scared and think you are abnormal, there are other women just like you who have never had an orgasm during sex and its just a sexual dysfunction that can be fixed. There could be several things that the man could not have done that is making you not to have an organism. This includes not providing you with the right amount of stimulation or not having enough foreplay.
News the best top 10 >>> Read more...
There are some women who can barely get aroused at all and no matter how hard a man tries to get their body stimulated they fail miserably. This could be because the woman is anxious about something or they are thinking too hard. Studies have indicated that failure of some women to feel aroused occurs in about 15 percent of the women population. The man might be left thinking that the woman does not love him and his better off leaving her than hanging on to someone he can barely turn on. Leaving is not necessary though. What you need to do is for both of you to seek some sort of professional help. This is because what she has is a sexual dysfunction that can be taken care of and with time maybe corrected. Dont loose a great love by thinking she simply doesnt love you.
There are some women who do not get an orgasm during sexual intercourse. It has actually been observed that about 40 percent of the women cannot get an orgasm during sex but could get one if they stimulated themselves or the man did it for them after the act. So if you have never had an orgasm during sex do not be scared and think you are abnormal, there are other women just like you who have never had an orgasm during sex and its just a sexual dysfunction that can be fixed. There could be several things that the man could not have done that is making you not to have an organism. This includes not providing you with the right amount of stimulation or not having enough foreplay.
News the best top 10 >>> Read more...
- Mood:Happy
- Music:Aerosmith
- Mood:humorous
- Music:Muddy Waters
You do not have to live near a Mayo Hospital or Health Care facility to reap the benefits of all their services. Online at mayoclinic.com you will find the best women's health clinic around. Log on to get their tools and advice for a healthier and happier life and answers to important women's health concerns.
At their online clinic women can find out everything concerning birth control, menopause, heart, mental health, breast concerns, menstruation, sexual questions and reproductive issues. There is a safe sex blog discussing everything from herpes, adolescent girls and STD's, do's and don'ts for reducing risks of STD's and more. Another feature at this site is a genetics blog that will let you know how your medical history can be an important tool for you to use. There is plenty of information here with resources you can count on.
All information >>> Read more...
At their online clinic women can find out everything concerning birth control, menopause, heart, mental health, breast concerns, menstruation, sexual questions and reproductive issues. There is a safe sex blog discussing everything from herpes, adolescent girls and STD's, do's and don'ts for reducing risks of STD's and more. Another feature at this site is a genetics blog that will let you know how your medical history can be an important tool for you to use. There is plenty of information here with resources you can count on.
All information >>> Read more...
- Mood:freewheeling
- Music:Jimi Hendrix
Sam said: "Getting an erection and after an embarrassing situation decided to talk to women. Store it at room temperature and away from excess heat and moisture. My previous treatment was based on penile injections it was so hard for me. Your treatment options with you. Do not take a double dose to make up for a missed one. Successful treatment restores sexual function to a satisfactory level for the man and his partner."
Looking for the better costs in discount meds? 2737 amerimedrx aq cialis nasacort nexium.
Americano news >>> Read more...
- Mood:bright
- Music:Kanye West
Alopecia Alopecia - is the absence or poredenie hair on the skin in their normal growth (more on Hair Loss skin of the head). 50% of men by age 50 years are clear signs of hair loss in male type. 37% of women in the same age indicate any signs of alopecia. The predominant age of the development of alopecia: alopecia androgen frequency increases in proportion to age; dermatomikoz Hair Loss head and traumatic alopecia often occur in children.
The reasons for alopecia :
1. Documents mature hair - are scattered hair loss, resulting in lower density ovoloseniya, but not to complete baldness. The reasons for the fallout of mature hair:
After childbirth as a result of physiological changes in body pregnant
Medicinal Products (hormonal contraceptives, drugs, slowing blood, retinoidy, beta-adrenoblokatory, anticancer drugs, interferon)
Stress (physical or mental)
Endocrine disorders (hypo-or hyperthyroidism, gipopituitarizm)
Dietary factors (eating disorders, iron deficiency, zinc)
. Documents growing hair - are scattered hair loss, including growing, with a possible complete baldness.
The reasons for the fallout of growing hair include:
Gribovidny mycosis
Radiation Therapy
Medicinal Products (anticancer drugs, allopurinol, bromokriptin)
Poisoning (bismuth, arsenic, gold, boric acid, thallium)
3. Scar alopecia - is the presence of the brilliant smooth areas on the Hair Loss skin of the head, not containing hair bulbs. The reasons for cicatricial alopecia:
Anomalies development and congenital malformations of hair bulbs
Infections (leprosy, syphilis, gerpeticheskaya disease, cutaneous leishmaniasis)
Bazalnokletochny cancer
pigment spots
The impact of physical factors (acid and alkali, extreme temperatures [burns, frostbitten], irradiation)
Rubtsuyuschayasya pemphigus
Polikistoz ovaries
hyperplasia of ovaries
Kartsinoid
Pituitary hyperplasia
Medicinal Products (testosterone, danazol, adrenocorticotropic hormone, anabolic steroids, progesterone)
5. Gnezdnaya alopecia - hair loss is acquired in the form of rounded pockets of various sizes on some sections of the skin of the head, eyebrows, beard area, not by scarring. When gnezdnoy alopecia sudden appears on the skin, head, face more rounded pockets full of hair without any other changes, the hair on the side pockets easily pull; pockets can grow, merge and lead to complete baldness. Causal factors gnezdnoy alopecia exactly unknown.
6. Traumatic alopecia - hair loss on some sections of the skin due to chronic trauma, in the early stages is not accompanied by scarring. The reasons:
Trihotillomaniya (exuberant appetite pull their hair)
Damage due zapletaniya braid or tugogo zavyazyvaniya bow
7. Dermatomikoz Hair Loss heads - limited pockets with the lack of hair on Hair Loss skin of the head, possibly a combination of inflammatory response, due to fungus. When dermatomikoze Hair Loss head there itching, peeling, inflammation.
The reasons:
Mushrooms kind mikrosporum
Mushrooms kind trihofiton
8. Genetic aspects. We know of at least 90 inherited diseases and syndromes involving alopetsiey:
congenital alopecia with keratosis of palms and soles
congenital total alopecia: combined with giant pigmented spots, seizures, mental retardation Gnezdnaya alopecia
Family alopecia
Total alopecia Diagnosis of alopecia Diagnosis of alopecia includes a number of studies:
Study of thyroid functions
Complete blood count (to detect possible violations of the functions of the immune system) The level of male sex hormones in the blood serum
The concentration of ferritin of blood plasma
Reaction von Wasserman for the exclusion of syphilis
The number of T-and B-lymphocytes (sometimes reduced in patients with gnezdnoy alopetsiey).
A sample of hair pandiculation: cautious pandiculation (no load) for the rod of hair in order to remove it; positive (hair easily removed) when gnezdnoy alopecia
microscopic examination of hair shaft
Study centers peeling using potassium hydroxide, is positive with dermatomikoze Hair Loss skin of the head. The use of antifungal drugs can lead to false positive results
Investigation of the existence of pockets of peeling fungi
Biopsy Hair Loss skin of the head with conventional microscopy and direct immunoflyuorestsentnadm studies to diagnose dermatomikoz Hair Loss skin of the head, diffuse gnezdnuyu cicatricial alopecia and alopecia, developed against the backdrop of hard currency, leaving the flat and sarcoidosis. Treatment of alopecia
Treatment of alopecia at vypadenii mature hair. Hair loss maximum
3 months after the causal effects (drugs, stress, dietary factors), after eliminating the causes ovolosenie quickly recovers
Treatment of alopecia at vypadenii growing hair. Hair loss begins in a few days or weeks after the causal effects ovolosenie recovering from the removal of the causes
Treatment of cicatricial alopecia. Effective treatment cicatricial alopecia - surgical (transplant skin graft or excision sites scarring)
Treatment of androgen alopecia. After 12 months, the local application of 2% solution of minoxidil 40% of the increase in hair various expressions. An alternative method of treatment - surgical
Treatment gnezdnoy alopecia. Usually the disease runs its own within 3 years without treatment, but frequent relapses. Apply sedatives, annoying rubbing alcohol (tincture peppers), hormone drugs for local use, drugs that increase sensitivity to light (beroksan) area in combination with ultraviolet irradiation
Treatment of traumatic alopecia. Healing can come only after the cessation of pulling out hair. You may need to intervene psychologist or psychiatrist. Successful treatment includes drug therapy, behavior and hypnosis
Hair Loss Treatment dermatomikoza head. Treatment of conduct during the 6-8 weeks ketokonazolom or other anti means. There is a need for thorough hand washing and laundry hats and towels. The course and prognosis, with alopecia
Documents mature and growing hair: permanent alopecia develops rarely
scar alopecia: hair bulbs are constantly exposed to damage
androgen alopecia: prognosis and treatment depend on over
Gnezdnaya alopecia: perhaps self-healing, but frequent relapses, with a total of gnezdnoy alopecia hair is usually not restored
traumatic alopecia: prognosis and during the correction depends on the successful conduct of patient
Dermatomikoz Hair Loss skin of the head: usually full recovery.
The best top 10 >>> Read more...
- Mood:friends
- Music:Hot Chip
HI MOn
Quick Action Plan for Diabetes
1. Nutrition is the key to getting rid of the cravings. Once you learn about nutrition (#6) and also cleansing out the toxins in the body by doing a colon, liver, and kidney cleanse. Youll be on your way to a healthy life.
2. Keep in mind that the goal of diabetic treatment and self-care is to restore blood sugar levels close to normal and to correct related metabolic disorders. One of the best ways to accomplish this is by eating small, frequent meals throughout the day that emphasize fresh, organic foods that are low on the glycemic scale, such as raw and lightly steamed vegetables, low sugar whole fruits, nuts, seeds, whole grains and legumes, yams, wild fish, poultry, lean cuts of beef, bison meal lamb or veal.
3. Minimize or eliminate your intake of simple carbohydrates and all sugars, as well as tobacco and processed junk foods. In addition, reduce your intake of alcohol and caffeine. Both alcohol and caffeine could be enjoyed on special occasions, rather than daily or even weekly habits.
4. Remain hydrated; drinking adequate quantities of pure water is essential for all aspects of your health. Must drink a gallon of water a day to maintain health. Your body is craving this much more than caffeine and sugar.
5. Engage in regular light exercise and stress reduction because they are keys to maintaining lower levels of blood sugar.
6. Consider supplementing with nutrients such as B-complex vitamins, vitamin C, vitamin E, chromium, magnesium, potassium, essential fatty acids, CoQ10, alpha lipoic acid, and vanadium. Stabilized rice bran supplements can also be helpful.
7. Herbs such as astragalus, bitter melon, fenugreek, raw garlic (one of the best for blood pressure), ginseng, Gymnema sylvestre, and huerque can also provide significant benefits.
8. If you have already developed Type I or Type II diabetes, combine the above self-care natural cures with professional care from a holistically oriented physician or other alternative health care practitioner. Particularly useful professional care therapies for treating and preventing diabetes include chelation therapy, food allergy testing, parasite testing and if necessary, cleansing, oxygen therapy, and professional dietary and nutritional counseling. Ayurveda and traditional Chinese medicine can also be helpful.
9. Prevention, if you are pre-disposed and managing a diabetic condition, is a life-long commitment. By committing to the guidelines above, you can significantly improve your symptoms, and, if you suffer from Type II diabetes, quite possibly reverse them altogether. Implementing diet and lifestyle changes can help improve your energy levels, and your confidence in your ability to experience greater health.
News >>> Read more...
- Mood:passionate
- Music:British Sea Power
I do not even know if i can coherently explain what is going on.
diana pilas took unitl a week or so ago to schedule Jailynns surgery.
I have been waiting since September for her to do so. It went from
Jan 15th to Jan 22nd because Dr K was going to be away. Now yesterday
i talked to the surgeons office and set up all of jailynns final
appointments. Today the surgeons office called to say they needed to
move Jailynns surgery to Jan 15th because the surgeon had to leave
early on jan 22nd to be in philadelphia The surgeon said if Dr k.
would agree to have a different neurologist fill in for him that we
could do the surgery without Dr K. Well after talking to Diana and
Dr K. he absolutely will not allow anyone else to fill in for him
because jailynn is HIS patient! saying it like she belongs to him,
with no sympathy for our situation. If jailynn cannot have a january
surgery we have to wait til may/june. I really do not like how
arrogant he was and how he showed no sympathy at all. Dr jallos
secreary (surgeon) was so nice and sympathetic. and come to find out
the surgeon and dr K are in town the begining of January, but the
surgeons schedule is full, Maybe if diana had tried to schedule teh
surgery in septmeber like she was suppossed to Jailynn could maybe
have gotten in the beginning of january. I am so angry, upset,
pissed whatever. I have been bawling. I really dislike Dr K because
of his arrogance now to the point i kinda want a different neuro. I
feel in my heart that this surgery is SUPPOSSED to happen in january
and when i get these intense gut feelings i am normally right, like
when he wanted to cancel her VEEG. jailynn has been having seizures
lately and i really wanted the surgery soon to prevent us increasing
her depakote, cause it has some nasty risks.
All information >>> Read more...
diana pilas took unitl a week or so ago to schedule Jailynns surgery.
I have been waiting since September for her to do so. It went from
Jan 15th to Jan 22nd because Dr K was going to be away. Now yesterday
i talked to the surgeons office and set up all of jailynns final
appointments. Today the surgeons office called to say they needed to
move Jailynns surgery to Jan 15th because the surgeon had to leave
early on jan 22nd to be in philadelphia The surgeon said if Dr k.
would agree to have a different neurologist fill in for him that we
could do the surgery without Dr K. Well after talking to Diana and
Dr K. he absolutely will not allow anyone else to fill in for him
because jailynn is HIS patient! saying it like she belongs to him,
with no sympathy for our situation. If jailynn cannot have a january
surgery we have to wait til may/june. I really do not like how
arrogant he was and how he showed no sympathy at all. Dr jallos
secreary (surgeon) was so nice and sympathetic. and come to find out
the surgeon and dr K are in town the begining of January, but the
surgeons schedule is full, Maybe if diana had tried to schedule teh
surgery in septmeber like she was suppossed to Jailynn could maybe
have gotten in the beginning of january. I am so angry, upset,
pissed whatever. I have been bawling. I really dislike Dr K because
of his arrogance now to the point i kinda want a different neuro. I
feel in my heart that this surgery is SUPPOSSED to happen in january
and when i get these intense gut feelings i am normally right, like
when he wanted to cancel her VEEG. jailynn has been having seizures
lately and i really wanted the surgery soon to prevent us increasing
her depakote, cause it has some nasty risks.
All information >>> Read more...
- Mood:playful
- Music:The Whigs
To gain approval for treating children, all a drug company has to do is submit two positive studies to the FDA to prove a medication is safe and effective for kids. However, after 20 years of feeding the new generation of antidepressants to tens of thousands of kids in clinical trials, the only one ever approved is Prozac.
Collectively, these antidepressants are referred to as SSRIs (selective serotonin reuptake inhibitors) and include Paxil, Zoloft, Celexa and Lexapro. When the term SSRIs is used, it often refers to their chemical cousins Effexor, Wellbutrin and Cymbalta as well.
The drug companies, by their sheer economic clout, have become the single most dominant influence in our healthcare system, and the ambiguities of childrens mental health and illness make child psychiatry the most vulnerable branch of medicine open to such influence, says Dr Lawrence Diller, a behavioral-developmental pediatrician and author of, The Last Normal Child, in the July 13, 2008, San Francisco Chronicle.
In this climate, he explains, drug company research money, professional medical education and direct advertisements to parents tilt families and doctors to biologically brain-based solutions, rather than non-drug (e.g., parenting and education) approaches.
That is why we are seeing famous (or infamous) Newsweek cover boys - like a 10-year-old who has taken 38 psychiatric medications in his short, unhappy life, he says.
Dr Joseph Glenmullen, author of Prozac Backlash, testified at a hearing before the US House Energy and Commerce Committee on February 10, 2005, and explained how important lawsuits have been in unearthing the internal company documents, which reveal the antidepressant-induced suicidality risk. Both the FDA and the pharmaceutical industry knew about this side effect over a decade ago, he said.
Dr Glenmullen noted that the FDA failed to adequately educate doctors and the public and called it a most dangerous scenario when neither the doctor nor the patient knows how to recognize antidepressant-induced suicidality.
He pointed out that only Prozac was FDA approved for depressed children, and all other antidepressants studied had failed to demonstrate they were more effective than placebo. He faulted the FDA for failing to require drug manufacturers to tell doctors in the labels that the drugs had been studied and failed to show efficacy.
He noted that one million American children were on antidepressants for everything from shyness to school anxiety to headaches to attention deficit disorder. How can the FDA allow this to happen when it has acknowledged that the drugs can make children suicidal? he asked.
Family doctors write 70% of prescriptions for antidepressants and know little about how to diagnose and treat antidepressant-induced suicidality, he pointed out.
Once the FDA approves a drug, doctors can prescribe it for any purpose, a practice called off-label prescribing. Many doctors prescribe many medications off label for children, but none do it as frequently as child psychiatrists, says Dr Diller.
He advises that none of the psychiatric drugs have been studied for more than two or three months regarding long-term safety or effectiveness with children, with the exception of stimulants used for ADHD. Drug companies oppose this kind of thorough follow-up on drugs not only because it is expensive, but because they dont really want to find out whether their drugs continue to work over time or if long-term side effects develop, he states in the paper, A Prescription for Disaster, published by Salon.com on May 23, 2002.
Currently, that kind of research is a job for the countrys trial lawyers, he writes.
But this de facto system of monitoring the effects of drugs requires many casualties before an adverse outcome is discovered or established in the medical and popular literature, Dr Diller points out.
Highly Paid Hustlers in motion
The failure of clinical trials to provide safety information about the effects of long-term use is at the heart of the debate about the legitimacy of prescribing psychotropic drugs for children, according to Vera Hassner Sharav, President of the Alliance for Human Research Protection in the 2003 paper, Children in Clinical Research: A Conflict of Moral Values, published in the American Journal of Bioethics.
No SSRI was approved for children before 2003. However, by the early 1990s, it didnt matter that they were not officially approved for use in children: they were commonly given to children as young as 6 years old, says Professor Jonathan Leo in the 2006 paper, The SSRI Trials in Children: Disturbing Implications for Academic Medicine.
He points out that the child psychiatry profession fully endorsed the use of these drugs well before the FDA approved them, and, in an even odder twist, he says, the profession endorsed the use of them well before any of the major studies in children were even published.It appears that one reason for doing the studies in the first place was to justify already well-accepted prescribing patterns, according to Professor Leo.
If a trend is created because everyone else is doing it then it appears that the child psychiatry professions use of these drugs in the late 1990s more closely resembled a trend instead of a logical scientific undertaking, he explains.
The first major studies claiming SSRIs were safe and effective for children began to appear in the late 1990s. In all the published studies, papers and poster presentations used at medical seminars, conferences and other events to expand the well-accepted prescribing patterns, to doctors in every field of medicine, there are the names of the same Highly-Paid Hustlers, also known as key opinion leaders, because they are supposedly so highly respected by their peers.
They include, but are not limited to, Drs Joseph Biederman, David Dunner, Graham Emslie, Daniel Geller, Robert Gibbons, Frederick Goodwin, Martin Keller, Andrew Leon, John Mann, John March, Charles Nemeroff, John Rush, Neal Ryan, David Shaffer and Karen Wagner.
Dr Biederman and the gang at Harvard almost single-handedly instigated the epidemic in the off-label prescribing of drug cocktails to children, of 2, 3 or even 4 drugs at a time, in combinations that have never been tested on animals much less humans. The mental illness always known as was now bipolar disorder, and in the mid-90s, Dr Biederman, and a few more opinion leaders started claiming that a great number of children were afflicted, possibly even as early as in the womb, some said.
Most parents have never heard of him, but Joseph Biederman of Harvard may be the United States most influential doctor when it comes to determining whether their children are normal or mentally ill, says Dr Diller, in an article entitled, Are Our Leading Pediatricians Drug Industry Shills? in the July 13, 2008, San Francisco Chronicle.
Biederman and his team, Dr Diller writes, are more responsible than anyone for a child bipolar epidemic sweeping America (and no other country) that has 2-year-olds on three or four psychiatric drugs.The science of childrens psychiatric medications is so primitive and Biedermans influence so great, he says, that when he merely mentions a drug during a presentation, tens of thousands of children within a year or two will end up taking that drug, or combination of drugs.This happens in the absence of a drug trial of any kind - instead, Dr Diller notes, the decision is based upon word of mouth among the 7,000 child psychiatrists in America.s why Iowa Sen. Charles Grassleys recent revelation that Biederman did not declare $1.6 million in drug company consulting fees is so important, scary and tragic, he says.
If true, Dr Diller notes, this scandal is yet one more stake in the heart of American academic medicines credibility with frontline doctors like him, and more importantly, with the parents of the children he deals with every day.
Until the profiteering scheme was set in place by publishing a couple bogus studies and then passing them around to doctors all over the country at medical seminars and conventions, manic-depression was unheard of in children. It still is in other counties.
Most parents are not aware of the life-long consequences of a childhood mental-illness diagnosis. Children with medical records showing treatment become ineligible for a wide range of occupations. An early diagnosis can also make it difficult to obtain health insurance for life.
In the age of computerized recordkeeping, there can be no deleting of this damning information. Just as there is no scientific way to prove that anyone has a mental disorder, there is no way to disprove it either. Once diagnosed, a child will never escape the label.
Dr Emslie was busy pumping out new marketing tools last year, this time in the form of a treatment guideline to promote the off-label use of psychiatric drugs to toddlers. However, the medical journals continue to publish this kind of trash.
He is the first author on a December 2007 paper in the Journal of the American Academy of Child Adolescent Psychiatry that reviewed the developmental considerations related to preschool psycho-pharmacological treatment, presenting current evidence bases for specific disorders in early childhood and described the recommended algorithms for medication use in 3- to 6-year-olds.
This Preschool Psychopharmacology Working Group claims it was developed to review existing literature and to develop recommendations to guide clinicians considering psycho-pharmacological treatment in very young children. The purpose of this effort, the authors note, is to promote responsible treatment of young children, recognizing that this will sometimes involve the use of medications.
Not one single psychiatric drug is approved for children under 6; not alone and not together with any other. Yet the Group says it has established algorithms for the treatment of ADHD, disruptive behavior disorders, major depressive disorder, bipolar disorder, anxiety disorders, posttraumatic stress disorder, obsessive-compulsive disorder, pervasive developmental disorders (such as autism) and primary sleep disorders.
On May 5, 2006, United Press International reported on a Duke University study where investigators studied 307 children between the ages of 2 and 5 and claimed they detected signs of depression, anxiety and other mental illnesses. The rate was about the same as with older children and not much lower than within adults, they said. UPI made sure to mention that the research was funded in part by the pharmaceutical giant Pfizer.
Judging by the results of this the recruited another 30 toddlers as potential customers for daily drug cocktails in one sweep. Notably missing from all the above lists of is a condition that could account for half of the stigmatizing labels in one age group, commonly known throughout time as the Terrible Twos.
Sad aftermath
Of all the harmful actions of modern psychiatry, the mass diagnosing and drugging of children is the most appalling with the most serious consequences for the future of individual lives and for society, says Dr Peter Breggin, author of the new book, Medication Madness.
Many children who end up seeking help from Dr Breggin are already on four or five drugs at one time. He says millions of children are growing up with drug-intoxicated brains.
Not only do these medications suppress spontaneity and volition, he warns, but the psychiatric approach teaches children that they cannot, without medication, learn to manage their own behavior. In effect, the children are taught that they cannot exercise and develop self-determination, autonomy or free will, he explains.
Pennsylvania psychiatrist Dr Stefan Kruszewski also warns that young children who are medicated do not learn to adapt and develop coping strategies as they move through the developmental stages of childhood.They rely on a false belief that drugs can solve problems, he says, rather than relying on their own innate creative potential or the help of family, friends, and schooling.Psychiatry was once plagued by ‘boundary violations, where physicians exploited the dependence of their patients, Dr David Healy explains in the 2006 paper, The Latest Mania: Selling Bipolar Disorder. But he says:
All the indications are that we are now in a new era of drug-related boundary violations. There is perhaps nowhere in medicine where this is more obvious than in the case of bipolar disorders, with adults treated with bizarre cocktails and children put on some of the most lethal drugs in medicine.The extensive prescription of these medications for children, Dr Diller warns, without adequate testing for safety and effectiveness in children constitutes a hidden time bomb that could explode with still more casualties.Catastrophic side effects may be rare, he says, but they become predictable when we treat so many children with so many drugs.There is nothing more despicable than a doctor knowingly telling normal children they are mentally ill for profit, says Dr Fred Baughman, author of, ADHD Fraud - How Psychiatry Makes Patients of Normal Children.Because the children made into are normal to begin with, Dr Baughman contends, those who treat them with psychiatric drugs are guilty not of an iatrogenic medical mistake, but a willful for-profit poisoning.What should we call it when children die pursuant to a fraudulent diagnosis, he asks. First degree murder? Second degree murder? Justifiable homicide? Manslaughter?
In an expert report recently submitted in litigation involving a Paxil-induced suicide by a 13-year-old boy, Dr Glenmullen discusses a case where that question begs to be answered when he tells the court: It is my opinion to a reasonable degree of medical probability that if GlaxoSmithKline had provided a warning all these years, Benjamin Bratt would still be alive today.
There are many families suffering all over the country as a result of the drugging-children-for-profit schemes set in place by the Highly-Paid Hustlers. For us it has been four and a half years without resolution or closure, says Mathy Milling Downing, whose daughter Candace hung herself in January 2004 after being prescribed Zoloft at age 12 because she was nervous when taking tests at school.
Every day hurts, Mathy says. One never gets over the loss. Prior to her death, the Downings saw no signs of Candace being depressed or suicidal.
They were not told to watch for signs of suicide. The doctor did not inform them that Zoloft was not approved for children, and they were assured that Zoloft was safe.
The Downings would later learn that their daughters physician was on Pfizers payroll. Although we realize that Candaces doctor only made about $12,000 acting as a Pfizer consultant, its not the amount that bothers us, Mathy says.
s the medical compromise. Its the lack of informed consent. Its placing economical gain above the well-being of an innocent child and a trusting family, she states.
I just want to know when Greed before Need will diminish and doctors will once again place a patients well-being first, she says, before financial gain.What has happened to the Hippocratic Oath that doctors are supposed to take? Mathy wants to know.
Rough estimates
In Let Them Eat Prozac, Dr Healy discusses how he reached his estimates for the high number of suicides and suicide attempts that could be attributed to Prozac alone. An April 2000 paper in the Archives of Psychiatry looked at the rates for suicide attempts on newer antidepressants compared to placebo and reported SSRI rates higher than placebo.
These figures made it possible for him to estimate how many people had made suicide attempts. If ten per thousand make an attempt on Prozac and five per thousand or less do so on placebo or other antidepressants, and if (as is conventionally estimated) 40 million people worldwide have had Prozac, he writes, then there will have been 200,000 more suicide attempts on Prozac than had Prozac not been used.Conventional wisdom is that there is one suicide for every ten attempts, he explains. These would give 20,000 suicides over and above the number who would have committed suicide if they had been left untreated or been treated with older agents.
Dr Healy then accessed the FDAs Adverse Event Database to look at suicides reported and found there were over 2,000 as of October 1999. The FDA estimated their database picked up only between one and ten per cent of serious adverse events, he writes.
This gives a spread between 20,000 and 200,000 suicides on Prozac, he concludes.
There is no way to know how many people have suffered needlessly because the drugmakers lied about the suicide risk for so many years. According to Dr Healy, aside from the need to save lives, if emergent suicide linked to a drug is not correctly attributed to treatment, patients suffer a long-lasting injury to their self-esteem and self-confidence as a consequence.
If patients have engaged in actual suicidal acts as a result of treatment and the connection to treatment is not made, given that prior suicide attempts appear to increase the risk of future successful suicides, it appears possible that the risk of a future successful suicide has been increased accordingly, he warns in a June 2003 briefing paper on Antidepressants and Suicide.
Evelyn Pringle
epringle05@yahoo.com
(Written as part of the Paxil Litigation Round-Up, Sponsored by Baum, Hedlund, Aristei Goldmans Pharmaceutical Litigation Department www.baumhedlundlaw.
Best sites about >>> Read more...
Collectively, these antidepressants are referred to as SSRIs (selective serotonin reuptake inhibitors) and include Paxil, Zoloft, Celexa and Lexapro. When the term SSRIs is used, it often refers to their chemical cousins Effexor, Wellbutrin and Cymbalta as well.
The drug companies, by their sheer economic clout, have become the single most dominant influence in our healthcare system, and the ambiguities of childrens mental health and illness make child psychiatry the most vulnerable branch of medicine open to such influence, says Dr Lawrence Diller, a behavioral-developmental pediatrician and author of, The Last Normal Child, in the July 13, 2008, San Francisco Chronicle.
In this climate, he explains, drug company research money, professional medical education and direct advertisements to parents tilt families and doctors to biologically brain-based solutions, rather than non-drug (e.g., parenting and education) approaches.
That is why we are seeing famous (or infamous) Newsweek cover boys - like a 10-year-old who has taken 38 psychiatric medications in his short, unhappy life, he says.
Dr Joseph Glenmullen, author of Prozac Backlash, testified at a hearing before the US House Energy and Commerce Committee on February 10, 2005, and explained how important lawsuits have been in unearthing the internal company documents, which reveal the antidepressant-induced suicidality risk. Both the FDA and the pharmaceutical industry knew about this side effect over a decade ago, he said.
Dr Glenmullen noted that the FDA failed to adequately educate doctors and the public and called it a most dangerous scenario when neither the doctor nor the patient knows how to recognize antidepressant-induced suicidality.
He pointed out that only Prozac was FDA approved for depressed children, and all other antidepressants studied had failed to demonstrate they were more effective than placebo. He faulted the FDA for failing to require drug manufacturers to tell doctors in the labels that the drugs had been studied and failed to show efficacy.
He noted that one million American children were on antidepressants for everything from shyness to school anxiety to headaches to attention deficit disorder. How can the FDA allow this to happen when it has acknowledged that the drugs can make children suicidal? he asked.
Family doctors write 70% of prescriptions for antidepressants and know little about how to diagnose and treat antidepressant-induced suicidality, he pointed out.
Once the FDA approves a drug, doctors can prescribe it for any purpose, a practice called off-label prescribing. Many doctors prescribe many medications off label for children, but none do it as frequently as child psychiatrists, says Dr Diller.
He advises that none of the psychiatric drugs have been studied for more than two or three months regarding long-term safety or effectiveness with children, with the exception of stimulants used for ADHD. Drug companies oppose this kind of thorough follow-up on drugs not only because it is expensive, but because they dont really want to find out whether their drugs continue to work over time or if long-term side effects develop, he states in the paper, A Prescription for Disaster, published by Salon.com on May 23, 2002.
Currently, that kind of research is a job for the countrys trial lawyers, he writes.
But this de facto system of monitoring the effects of drugs requires many casualties before an adverse outcome is discovered or established in the medical and popular literature, Dr Diller points out.
Highly Paid Hustlers in motion
The failure of clinical trials to provide safety information about the effects of long-term use is at the heart of the debate about the legitimacy of prescribing psychotropic drugs for children, according to Vera Hassner Sharav, President of the Alliance for Human Research Protection in the 2003 paper, Children in Clinical Research: A Conflict of Moral Values, published in the American Journal of Bioethics.
No SSRI was approved for children before 2003. However, by the early 1990s, it didnt matter that they were not officially approved for use in children: they were commonly given to children as young as 6 years old, says Professor Jonathan Leo in the 2006 paper, The SSRI Trials in Children: Disturbing Implications for Academic Medicine.
He points out that the child psychiatry profession fully endorsed the use of these drugs well before the FDA approved them, and, in an even odder twist, he says, the profession endorsed the use of them well before any of the major studies in children were even published.It appears that one reason for doing the studies in the first place was to justify already well-accepted prescribing patterns, according to Professor Leo.
If a trend is created because everyone else is doing it then it appears that the child psychiatry professions use of these drugs in the late 1990s more closely resembled a trend instead of a logical scientific undertaking, he explains.
The first major studies claiming SSRIs were safe and effective for children began to appear in the late 1990s. In all the published studies, papers and poster presentations used at medical seminars, conferences and other events to expand the well-accepted prescribing patterns, to doctors in every field of medicine, there are the names of the same Highly-Paid Hustlers, also known as key opinion leaders, because they are supposedly so highly respected by their peers.
They include, but are not limited to, Drs Joseph Biederman, David Dunner, Graham Emslie, Daniel Geller, Robert Gibbons, Frederick Goodwin, Martin Keller, Andrew Leon, John Mann, John March, Charles Nemeroff, John Rush, Neal Ryan, David Shaffer and Karen Wagner.
Dr Biederman and the gang at Harvard almost single-handedly instigated the epidemic in the off-label prescribing of drug cocktails to children, of 2, 3 or even 4 drugs at a time, in combinations that have never been tested on animals much less humans. The mental illness always known as was now bipolar disorder, and in the mid-90s, Dr Biederman, and a few more opinion leaders started claiming that a great number of children were afflicted, possibly even as early as in the womb, some said.
Most parents have never heard of him, but Joseph Biederman of Harvard may be the United States most influential doctor when it comes to determining whether their children are normal or mentally ill, says Dr Diller, in an article entitled, Are Our Leading Pediatricians Drug Industry Shills? in the July 13, 2008, San Francisco Chronicle.
Biederman and his team, Dr Diller writes, are more responsible than anyone for a child bipolar epidemic sweeping America (and no other country) that has 2-year-olds on three or four psychiatric drugs.The science of childrens psychiatric medications is so primitive and Biedermans influence so great, he says, that when he merely mentions a drug during a presentation, tens of thousands of children within a year or two will end up taking that drug, or combination of drugs.This happens in the absence of a drug trial of any kind - instead, Dr Diller notes, the decision is based upon word of mouth among the 7,000 child psychiatrists in America.s why Iowa Sen. Charles Grassleys recent revelation that Biederman did not declare $1.6 million in drug company consulting fees is so important, scary and tragic, he says.
If true, Dr Diller notes, this scandal is yet one more stake in the heart of American academic medicines credibility with frontline doctors like him, and more importantly, with the parents of the children he deals with every day.
Until the profiteering scheme was set in place by publishing a couple bogus studies and then passing them around to doctors all over the country at medical seminars and conventions, manic-depression was unheard of in children. It still is in other counties.
Most parents are not aware of the life-long consequences of a childhood mental-illness diagnosis. Children with medical records showing treatment become ineligible for a wide range of occupations. An early diagnosis can also make it difficult to obtain health insurance for life.
In the age of computerized recordkeeping, there can be no deleting of this damning information. Just as there is no scientific way to prove that anyone has a mental disorder, there is no way to disprove it either. Once diagnosed, a child will never escape the label.
Dr Emslie was busy pumping out new marketing tools last year, this time in the form of a treatment guideline to promote the off-label use of psychiatric drugs to toddlers. However, the medical journals continue to publish this kind of trash.
He is the first author on a December 2007 paper in the Journal of the American Academy of Child Adolescent Psychiatry that reviewed the developmental considerations related to preschool psycho-pharmacological treatment, presenting current evidence bases for specific disorders in early childhood and described the recommended algorithms for medication use in 3- to 6-year-olds.
This Preschool Psychopharmacology Working Group claims it was developed to review existing literature and to develop recommendations to guide clinicians considering psycho-pharmacological treatment in very young children. The purpose of this effort, the authors note, is to promote responsible treatment of young children, recognizing that this will sometimes involve the use of medications.
Not one single psychiatric drug is approved for children under 6; not alone and not together with any other. Yet the Group says it has established algorithms for the treatment of ADHD, disruptive behavior disorders, major depressive disorder, bipolar disorder, anxiety disorders, posttraumatic stress disorder, obsessive-compulsive disorder, pervasive developmental disorders (such as autism) and primary sleep disorders.
On May 5, 2006, United Press International reported on a Duke University study where investigators studied 307 children between the ages of 2 and 5 and claimed they detected signs of depression, anxiety and other mental illnesses. The rate was about the same as with older children and not much lower than within adults, they said. UPI made sure to mention that the research was funded in part by the pharmaceutical giant Pfizer.
Judging by the results of this the recruited another 30 toddlers as potential customers for daily drug cocktails in one sweep. Notably missing from all the above lists of is a condition that could account for half of the stigmatizing labels in one age group, commonly known throughout time as the Terrible Twos.
Sad aftermath
Of all the harmful actions of modern psychiatry, the mass diagnosing and drugging of children is the most appalling with the most serious consequences for the future of individual lives and for society, says Dr Peter Breggin, author of the new book, Medication Madness.
Many children who end up seeking help from Dr Breggin are already on four or five drugs at one time. He says millions of children are growing up with drug-intoxicated brains.
Not only do these medications suppress spontaneity and volition, he warns, but the psychiatric approach teaches children that they cannot, without medication, learn to manage their own behavior. In effect, the children are taught that they cannot exercise and develop self-determination, autonomy or free will, he explains.
Pennsylvania psychiatrist Dr Stefan Kruszewski also warns that young children who are medicated do not learn to adapt and develop coping strategies as they move through the developmental stages of childhood.They rely on a false belief that drugs can solve problems, he says, rather than relying on their own innate creative potential or the help of family, friends, and schooling.Psychiatry was once plagued by ‘boundary violations, where physicians exploited the dependence of their patients, Dr David Healy explains in the 2006 paper, The Latest Mania: Selling Bipolar Disorder. But he says:
All the indications are that we are now in a new era of drug-related boundary violations. There is perhaps nowhere in medicine where this is more obvious than in the case of bipolar disorders, with adults treated with bizarre cocktails and children put on some of the most lethal drugs in medicine.The extensive prescription of these medications for children, Dr Diller warns, without adequate testing for safety and effectiveness in children constitutes a hidden time bomb that could explode with still more casualties.Catastrophic side effects may be rare, he says, but they become predictable when we treat so many children with so many drugs.There is nothing more despicable than a doctor knowingly telling normal children they are mentally ill for profit, says Dr Fred Baughman, author of, ADHD Fraud - How Psychiatry Makes Patients of Normal Children.Because the children made into are normal to begin with, Dr Baughman contends, those who treat them with psychiatric drugs are guilty not of an iatrogenic medical mistake, but a willful for-profit poisoning.What should we call it when children die pursuant to a fraudulent diagnosis, he asks. First degree murder? Second degree murder? Justifiable homicide? Manslaughter?
In an expert report recently submitted in litigation involving a Paxil-induced suicide by a 13-year-old boy, Dr Glenmullen discusses a case where that question begs to be answered when he tells the court: It is my opinion to a reasonable degree of medical probability that if GlaxoSmithKline had provided a warning all these years, Benjamin Bratt would still be alive today.
There are many families suffering all over the country as a result of the drugging-children-for-profit schemes set in place by the Highly-Paid Hustlers. For us it has been four and a half years without resolution or closure, says Mathy Milling Downing, whose daughter Candace hung herself in January 2004 after being prescribed Zoloft at age 12 because she was nervous when taking tests at school.
Every day hurts, Mathy says. One never gets over the loss. Prior to her death, the Downings saw no signs of Candace being depressed or suicidal.
They were not told to watch for signs of suicide. The doctor did not inform them that Zoloft was not approved for children, and they were assured that Zoloft was safe.
The Downings would later learn that their daughters physician was on Pfizers payroll. Although we realize that Candaces doctor only made about $12,000 acting as a Pfizer consultant, its not the amount that bothers us, Mathy says.
s the medical compromise. Its the lack of informed consent. Its placing economical gain above the well-being of an innocent child and a trusting family, she states.
I just want to know when Greed before Need will diminish and doctors will once again place a patients well-being first, she says, before financial gain.What has happened to the Hippocratic Oath that doctors are supposed to take? Mathy wants to know.
Rough estimates
In Let Them Eat Prozac, Dr Healy discusses how he reached his estimates for the high number of suicides and suicide attempts that could be attributed to Prozac alone. An April 2000 paper in the Archives of Psychiatry looked at the rates for suicide attempts on newer antidepressants compared to placebo and reported SSRI rates higher than placebo.
These figures made it possible for him to estimate how many people had made suicide attempts. If ten per thousand make an attempt on Prozac and five per thousand or less do so on placebo or other antidepressants, and if (as is conventionally estimated) 40 million people worldwide have had Prozac, he writes, then there will have been 200,000 more suicide attempts on Prozac than had Prozac not been used.Conventional wisdom is that there is one suicide for every ten attempts, he explains. These would give 20,000 suicides over and above the number who would have committed suicide if they had been left untreated or been treated with older agents.
Dr Healy then accessed the FDAs Adverse Event Database to look at suicides reported and found there were over 2,000 as of October 1999. The FDA estimated their database picked up only between one and ten per cent of serious adverse events, he writes.
This gives a spread between 20,000 and 200,000 suicides on Prozac, he concludes.
There is no way to know how many people have suffered needlessly because the drugmakers lied about the suicide risk for so many years. According to Dr Healy, aside from the need to save lives, if emergent suicide linked to a drug is not correctly attributed to treatment, patients suffer a long-lasting injury to their self-esteem and self-confidence as a consequence.
If patients have engaged in actual suicidal acts as a result of treatment and the connection to treatment is not made, given that prior suicide attempts appear to increase the risk of future successful suicides, it appears possible that the risk of a future successful suicide has been increased accordingly, he warns in a June 2003 briefing paper on Antidepressants and Suicide.
Evelyn Pringle
epringle05@yahoo.com
(Written as part of the Paxil Litigation Round-Up, Sponsored by Baum, Hedlund, Aristei Goldmans Pharmaceutical Litigation Department www.baumhedlundlaw.
Best sites about >>> Read more...
- Mood:
happy - Music:Basia Bulat
.
EdHardyShopper.com - is an information site that provides information on deals online for clothing. EdHardyShopper.com is not endorsed by Ed Hardy Inc. All trademarks are owned by their respective owners. Redistribution in any form is prohibited. We are not affiliated at all with Ed Hardy. We appreciate fun style and want to help consumers locate a good deal online. ED HARDY, DON ED HARDY, ED HARDY TATTOO, HARDY, HARDY LIFE, LOVE KILLS SLOWLY, AND THE ED HARDY LOGO are trademarks or registered trademarks of Hardy Life, LLC., in the United States and other countries. Copyright © 2003-2008 Hardy Life, LLC. All Rights Reserved. Ed Hardy, Don Ed Hardy, Ed Hardy Tattoo, Hardy, Hardy Life, and the Ed Hardy logo are registered trademarks of Hardy Life, LLC.
Americano top 10 >>> Read more...
EdHardyShopper.com - is an information site that provides information on deals online for clothing. EdHardyShopper.com is not endorsed by Ed Hardy Inc. All trademarks are owned by their respective owners. Redistribution in any form is prohibited. We are not affiliated at all with Ed Hardy. We appreciate fun style and want to help consumers locate a good deal online. ED HARDY, DON ED HARDY, ED HARDY TATTOO, HARDY, HARDY LIFE, LOVE KILLS SLOWLY, AND THE ED HARDY LOGO are trademarks or registered trademarks of Hardy Life, LLC., in the United States and other countries. Copyright © 2003-2008 Hardy Life, LLC. All Rights Reserved. Ed Hardy, Don Ed Hardy, Ed Hardy Tattoo, Hardy, Hardy Life, and the Ed Hardy logo are registered trademarks of Hardy Life, LLC.
Americano top 10 >>> Read more...
- Mood:freewheeling
- Music:Gregory Isaacs
Wage increases for the IA Basic Agreement consist of 3% effective 8/2/09; another 3% effective 8/1/10, and another 3% effective 7/31/11. For Locals 52 and 161 (NY), it's 3%/3%/3% increases on the effective dates of those agreements.
Concerning Pension and Health:
The AMPTP believes the cost of its deal with IATSE amounts to an increase of about 3.8% a year for the next three years. But that doesn't include a $233 million savings to employers in Health Plan "modifications" agreed to by the union.
Both sides agreed that, effective 7/31/11, the Health Plan will change the standards for continuing eligibility from a requirement of working 300 hours to 400 hours.
As for other pension and health terms, the AMPTP believes the employers agreed to increase hourly contribution rates in the agreegate by 35 cents per hour as of 8/2/08; an additional 35 cents an hour effective 8/1/10, and an additional 35 cents per hour effective on 8/1/11.
Additionally, the employers committed to pay an additional 15 cents an hour if consultants' projections show that active reserves drop below 10 months but not earlier than 8/1/10. If that happens, then the employers will be obligated to contribute an additional 15 cents effective 7/31/11 which can go into effect earlier if the reserves dip below 6 months for active reserves and 8 months for retirees.
The employers say that, as an additional funding mechanism after those options, IATSE will "reallocate" an additional 1% from wages or their IAP.
Pension retirees will receive 13th and 14th checks for all three years.
Concerning TV Made For Basic Cable Productions:
Employers say that the union agreed to continue to grant waivers providing that for pilots and one-hour series made for basic cable, the employers can use the terms and discounts of the MOW sideletter for the first season of a series, and then start using the terms and conditions of the one-hour series sideletter.
Concerning Original Programs Made For New Media:
Employers agreed to exclusive recognition for IATSE for the geographic scope of their current agreements for entertainment programs of the type traditionally covered by their deals.
Employers agreed that derivative programs are all covered except for those produced under the IA Videotape Agreement which will be treated the same as original programs made for New Media.
Employers believe that, as for as covered programs, rates and terms are generally freely negotiable. Union security, no-strike/lockout, and grievance and arbitration provisions will apply. No mandatory staffing. Full interchange of job functions. If a person is required to work on a derivative project on the same day as a source production, they must be paid as a continuation of their regular rates and work conditions.
Unions think that covered employees may be assigned to the derivative prodution as part of the regular workday on the source production. Extended workday or overtime payments, asapplicable, would be triggered if the work extends past the contractual workday. Otherwise, terms and conditions of employment are freely negotiable.
Union thinks that in all cases pension and health contributions will be due in the normal amounts.
Union agrees that IATSE shall administer the grievance and arbitration of the New Media provisions and to remove the Step 2 provisions of the basic agreement grievance and arbitration procedure.
The union understands that original productions will be covered if the cost of production is over either $15,000 per minute as exhibite, or $300,000 per single production, or $500,000 for a series order.
The employers claim there's no coverage for experimental programs the same as under the DGA/WGA/and AFTRA agreements unless they have 4 or more employees on the West Coast Industry Experience Roster. Unions say that, in the case of local unions with no Roster, or where the Roster does not apply, original productions will be covered if said employees who've worked 30 or more days under any motion picture agreement. (Companies say employees for 30 days over 3 years under terms of those agreements.) Union thinks that, for those productions that don't otherwise trigger the agreement, the employer may utilize the agreement for experimental productions upon written notification at least two weeks prior to commencing the given production.
Employers think there are certain limited coverage exclusions for persons who are not specifically charged to overhead who work on the projects, and union believes the following classifications are excluded for purpoises of triggering the application of the agreement: (story analysts, projectionists, in-house publicists [not unit publicists], post-production with the exception of the Editor and Assistant Editor).
On the issue of union security, union believes that an employee employed on a New Media production shall become and remain in good standing of IATSE and the appropriate Local on and after the 30th day of covered work following thefirst day of employment or the effective date of such respectie agreements between companies and the several Unions, which is later. The forgoing requirements of Union membership as a condition of employment shall be subject to the obligations of the parties under the law. All other provisions of Union Security Provisions of applicable agreements shall be extende to New Media. Qualified status on the CSATF Industry Experience Roster wshall not be a condition of employmnt. Covered employees shall receive credit for Roster placement for days worked on New Media production.
Employers think they reached an understanding with IATSE on contracting out of programs.
Concerning Re-use of Programs Transmitted In New Media:
Employers agreed to pay residuals at 5.4% for derivative and original New Media programs when released originally on a consumer free ad-supported platform and then subsequently on a consumer pay platform for Electronic Sell-Through or download to rent (ITunes, Movie-Link, etc) after a 26-week period.
Employers agreed to pay if New Media programs are released on traditional media platforms (basic cable, pay TV, home video) under the normal rules for making Supplemental Markets payments.
Employers agreed that for Electronic Sell-Through and download to own, companies will pay 8.1% of 20% of producers gross for first 50,000 units sold, and 14.625% on sales thereafter, if a theaterical program is released after 8/1/09. If it's a TV program released after 8/1/09 for sale, companies will pay 8.1% of 100,000 units sold and then 15.75% for all sales thereafter. It's unclear if the unions have agreed to these terms or not.
Employers say IATSE (but not the Motion Picture Industry Pensions and Health Plans also which unions initially wanted) will have the same inspection rights on the contract's New Media license agreements that was given to the other unions. Union believes it's all un-redacted copies of all license, distribution, and other agreements pertaining to New Media exploitation on a quarterly basis. Union also believes the payments will be accompanied by detailed information as to the medium and source generating the receipts, as well as unredacted copies of all corollary distributor-, sub-distributor-, and exhibitor statements. Union believes in addition that each employer upon request will provide IATSE with data in its possession or the possession of its related and affiliated entites regarding the New Media exploitation of covered pictures, such as number of downloads or streams by source and ad rates.
Union refers to "Sideletter to Interim Agreement Regarding Re-Use In New Media".
Employers say there's a "Sunset" Clause for all of the New Media deal. The union says this about the "Sunset" clause: that both particies recognize that these provisions are being negotiated at a time when the business models and patterns of usage of motion pictures and other productions in New Media ae in the process of exploration, experimentation and innovation. Therefore, all the provisions relating to New Media expire on the termination date of the Basic Agreement and will be of no force and effect thereafter. No later than 60 days before that expiration date, the parties will meet to negotiate new terms and conditions in New Media.
The union also believes the parties' negotiation for the successor agreements will be based on the conditions that exist and reasonably can be forecast at that time. For example, with respect to the formula for the electronic sell-through of motion pictures and television programs, the growth of electronic sell-through could adversely impact traditional home video sales. In future negotiations, the parties agree that the criteria to be considered in good faith in determining whether the electronic sell-through residual should be increased or deceased include patterns of cannibalization of the home video market and changes in the wholesale price.
The best top 10 >>> Read more...
Concerning Pension and Health:
The AMPTP believes the cost of its deal with IATSE amounts to an increase of about 3.8% a year for the next three years. But that doesn't include a $233 million savings to employers in Health Plan "modifications" agreed to by the union.
Both sides agreed that, effective 7/31/11, the Health Plan will change the standards for continuing eligibility from a requirement of working 300 hours to 400 hours.
As for other pension and health terms, the AMPTP believes the employers agreed to increase hourly contribution rates in the agreegate by 35 cents per hour as of 8/2/08; an additional 35 cents an hour effective 8/1/10, and an additional 35 cents per hour effective on 8/1/11.
Additionally, the employers committed to pay an additional 15 cents an hour if consultants' projections show that active reserves drop below 10 months but not earlier than 8/1/10. If that happens, then the employers will be obligated to contribute an additional 15 cents effective 7/31/11 which can go into effect earlier if the reserves dip below 6 months for active reserves and 8 months for retirees.
The employers say that, as an additional funding mechanism after those options, IATSE will "reallocate" an additional 1% from wages or their IAP.
Pension retirees will receive 13th and 14th checks for all three years.
Concerning TV Made For Basic Cable Productions:
Employers say that the union agreed to continue to grant waivers providing that for pilots and one-hour series made for basic cable, the employers can use the terms and discounts of the MOW sideletter for the first season of a series, and then start using the terms and conditions of the one-hour series sideletter.
Concerning Original Programs Made For New Media:
Employers agreed to exclusive recognition for IATSE for the geographic scope of their current agreements for entertainment programs of the type traditionally covered by their deals.
Employers agreed that derivative programs are all covered except for those produced under the IA Videotape Agreement which will be treated the same as original programs made for New Media.
Employers believe that, as for as covered programs, rates and terms are generally freely negotiable. Union security, no-strike/lockout, and grievance and arbitration provisions will apply. No mandatory staffing. Full interchange of job functions. If a person is required to work on a derivative project on the same day as a source production, they must be paid as a continuation of their regular rates and work conditions.
Unions think that covered employees may be assigned to the derivative prodution as part of the regular workday on the source production. Extended workday or overtime payments, asapplicable, would be triggered if the work extends past the contractual workday. Otherwise, terms and conditions of employment are freely negotiable.
Union thinks that in all cases pension and health contributions will be due in the normal amounts.
Union agrees that IATSE shall administer the grievance and arbitration of the New Media provisions and to remove the Step 2 provisions of the basic agreement grievance and arbitration procedure.
The union understands that original productions will be covered if the cost of production is over either $15,000 per minute as exhibite, or $300,000 per single production, or $500,000 for a series order.
The employers claim there's no coverage for experimental programs the same as under the DGA/WGA/and AFTRA agreements unless they have 4 or more employees on the West Coast Industry Experience Roster. Unions say that, in the case of local unions with no Roster, or where the Roster does not apply, original productions will be covered if said employees who've worked 30 or more days under any motion picture agreement. (Companies say employees for 30 days over 3 years under terms of those agreements.) Union thinks that, for those productions that don't otherwise trigger the agreement, the employer may utilize the agreement for experimental productions upon written notification at least two weeks prior to commencing the given production.
Employers think there are certain limited coverage exclusions for persons who are not specifically charged to overhead who work on the projects, and union believes the following classifications are excluded for purpoises of triggering the application of the agreement: (story analysts, projectionists, in-house publicists [not unit publicists], post-production with the exception of the Editor and Assistant Editor).
On the issue of union security, union believes that an employee employed on a New Media production shall become and remain in good standing of IATSE and the appropriate Local on and after the 30th day of covered work following thefirst day of employment or the effective date of such respectie agreements between companies and the several Unions, which is later. The forgoing requirements of Union membership as a condition of employment shall be subject to the obligations of the parties under the law. All other provisions of Union Security Provisions of applicable agreements shall be extende to New Media. Qualified status on the CSATF Industry Experience Roster wshall not be a condition of employmnt. Covered employees shall receive credit for Roster placement for days worked on New Media production.
Employers think they reached an understanding with IATSE on contracting out of programs.
Concerning Re-use of Programs Transmitted In New Media:
Employers agreed to pay residuals at 5.4% for derivative and original New Media programs when released originally on a consumer free ad-supported platform and then subsequently on a consumer pay platform for Electronic Sell-Through or download to rent (ITunes, Movie-Link, etc) after a 26-week period.
Employers agreed to pay if New Media programs are released on traditional media platforms (basic cable, pay TV, home video) under the normal rules for making Supplemental Markets payments.
Employers agreed that for Electronic Sell-Through and download to own, companies will pay 8.1% of 20% of producers gross for first 50,000 units sold, and 14.625% on sales thereafter, if a theaterical program is released after 8/1/09. If it's a TV program released after 8/1/09 for sale, companies will pay 8.1% of 100,000 units sold and then 15.75% for all sales thereafter. It's unclear if the unions have agreed to these terms or not.
Employers say IATSE (but not the Motion Picture Industry Pensions and Health Plans also which unions initially wanted) will have the same inspection rights on the contract's New Media license agreements that was given to the other unions. Union believes it's all un-redacted copies of all license, distribution, and other agreements pertaining to New Media exploitation on a quarterly basis. Union also believes the payments will be accompanied by detailed information as to the medium and source generating the receipts, as well as unredacted copies of all corollary distributor-, sub-distributor-, and exhibitor statements. Union believes in addition that each employer upon request will provide IATSE with data in its possession or the possession of its related and affiliated entites regarding the New Media exploitation of covered pictures, such as number of downloads or streams by source and ad rates.
Union refers to "Sideletter to Interim Agreement Regarding Re-Use In New Media".
Employers say there's a "Sunset" Clause for all of the New Media deal. The union says this about the "Sunset" clause: that both particies recognize that these provisions are being negotiated at a time when the business models and patterns of usage of motion pictures and other productions in New Media ae in the process of exploration, experimentation and innovation. Therefore, all the provisions relating to New Media expire on the termination date of the Basic Agreement and will be of no force and effect thereafter. No later than 60 days before that expiration date, the parties will meet to negotiate new terms and conditions in New Media.
The union also believes the parties' negotiation for the successor agreements will be based on the conditions that exist and reasonably can be forecast at that time. For example, with respect to the formula for the electronic sell-through of motion pictures and television programs, the growth of electronic sell-through could adversely impact traditional home video sales. In future negotiations, the parties agree that the criteria to be considered in good faith in determining whether the electronic sell-through residual should be increased or deceased include patterns of cannibalization of the home video market and changes in the wholesale price.
The best top 10 >>> Read more...
- Mood:swaggering
- Music:Mudvayne